We undertook a non-concurrent prospective study of 191 Puerto Rican @entity1 from August 1993 to April 1994. All @entity1 had @entity1538 ( @entity1538 ) (age ranged from 50 to 80 yrs; mean = 65 yrs). @entity1 's symptomatology associated to side effects of their @entity726 medicadons was reviewed. Incidence percent of ocular and/or systemic side effects per medication were: @entity8412 45.0%; @entity9004 42.0%; @entity6839 27.3%; @entity2134 100%; @entity61661 14.0%; and @entity3791 250 mg 64.1%. Incidence percent of ocular and/or systemic side effects of topical beta-blockers used with concomittant medications were determined. Ocular side effects were more frequent in @entity1 using @entity8412 44.2% than in those @entity1 using @entity9004 42.0%, 8.5% of @entity1 using @entity8412 did report systemic side effects. No systemic side effects were reported by @entity1 using @entity9004 . Ocular side effects in @entity1 using @entity2134 were frequent (100%); whereas the frequency of systemic side effects was low (6.1%). Systemic side effects were common in @entity1 using carbonic anhydrase inhibitors. These results suggest that non-selective and cardio-selective topical Beta-blockers, differ in their ocular or systemic side effects.

Adverse drugs reactions associated with XXXX medications.

@entity1 :: ('9606', 'Species') :: ['patients', 'Patient'] @entity1538 :: ('MESH:D005902', 'Disease') :: ['OAG', 'open angle glaucoma'] @entity8412 :: ('MESH:D002040', 'Chemical') :: ['levobunolol'] @entity6839 :: ('MESH:D013999', 'Chemical') :: ['timolol'] @entity3791 :: ('MESH:D000086', 'Chemical') :: ['acetazolamide'] @entity726 :: ('MESH:D005901', 'Disease') :: ['glaucoma'] @entity2134 :: ('MESH:D010862', 'Chemical') :: ['pilocarpine'] @entity61661 :: ('MESH:C015173', 'Chemical') :: ['dipivefrin'] @entity9004 :: ('MESH:D015784', 'Chemical') :: ['betaxolol']
@entity726 :: (MESH:D005901,Disease) :: ['glaucoma']
